LOS ANGELES-The Law Offices of Frank R. Cruz announces an investigation of DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM) on behalf of investors concerning the Company’s possible violations of federal securities laws.
“execution did not meet [its] high standards.”
f you are a shareholder who suffered a loss, click here to participate.
On July 25, 2024, after the market closed, DexCom announced its second quarter 2024 financial results, including $1.004 billion revenue, in a press release stating the Company’s “execution did not meet [its] high standards.” The Company also lowered its full year 2024 guidance, expecting between $4 billion and $4.05 billion revenue, due to “certain unique items impacting 2024 seasonality.”
On this news, the Company’s stock price fell $43.85, or 40.7%, to close at $64.00 per share on July 26, 2024, thereby injuring investors.
Follow us for updates on Twitter: twitter.com/FRC_LAW.
If you purchased DexCom securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com
